Literature DB >> 20208365

Binding of Norovirus virus-like particles (VLPs) to human intestinal Caco-2 cells and the suppressive effect of pasteurized bovine colostrum on this VLP binding.

Kosuke Murakami1, Sayaka Suzuki, Naohito Aoki, Tetsuya Okajima, Daita Nadano, Kenji Uchida, Kousaku Yamashita, Tomoichiro Oka, Kazuhiko Katayama, Naokazu Takeda, Tsukasa Matsuda.   

Abstract

Noroviruses (NoVs), which cannot be grown in cell culture, are a major infectious agent of gastroenteritis. An in vitro assay system was established for the evaluation of NoV binding to enterocytes using virus-like particles (VLPs) produced in a baculovirus system expressing a NoV VP1 capsid protein. After confirmation of the purity by MS analysis, VLPs were incubated with human intestinal Caco-2 cells. NoV VLPs were detected clearly by confocal laser microscopy only on a certain population of Caco-2 cells, and were semi-quantified by immunoblotting of cell lysates. Then the suppressive effect of pasteurized bovine colostrum was analyzed on the VLP binding to Caco-2 cells by immunoblotting. The colostrum reduced VLP binding in a dose-dependent manner, at about 50% suppression with 12.5 microg of the colostral proteins. Furthermore, the colostrum contained IgG antibodies reacting to VLPs, suggesting that cross-reactive antibodies in the bovine colostrums block human NoV binding to intestinal cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20208365     DOI: 10.1271/bbb.90729

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  6 in total

1.  Effect of grape seed extract on human norovirus GII.4 and murine norovirus 1 in viral suspensions, on stainless steel discs, and in lettuce wash water.

Authors:  Dan Li; Leen Baert; Dongsheng Zhang; Ming Xia; Weiming Zhong; Els Van Coillie; Xi Jiang; Mieke Uyttendaele
Journal:  Appl Environ Microbiol       Date:  2012-08-17       Impact factor: 4.792

2.  Norovirus binding to intestinal epithelial cells is independent of histo-blood group antigens.

Authors:  Kosuke Murakami; Chie Kurihara; Tomoichiro Oka; Takashi Shimoike; Yoshiki Fujii; Reiko Takai-Todaka; YoungBin Park; Takaji Wakita; Tsukasa Matsuda; Ryota Hokari; Soichiro Miura; Kazuhiko Katayama
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

3.  Development of a Surrogate Neutralization Assay for Norovirus Vaccine Evaluation at the Cellular Level.

Authors:  Xiaoli Wang; Shuxia Wang; Chao Zhang; Yu Zhou; Pei Xiong; Qingwei Liu; Zhong Huang
Journal:  Viruses       Date:  2018-01-05       Impact factor: 5.048

Review 4.  Comparative evaluation of recombinant protein production in different biofactories: the green perspective.

Authors:  Matilde Merlin; Elisa Gecchele; Stefano Capaldi; Mario Pezzotti; Linda Avesani
Journal:  Biomed Res Int       Date:  2014-03-12       Impact factor: 3.411

5.  Noroviral p-particles as an in vitro model to assess the interactions of noroviruses with probiotics.

Authors:  Antonio Rubio-del-Campo; José M Coll-Marqués; María J Yebra; Javier Buesa; Gaspar Pérez-Martínez; Vicente Monedero; Jesús Rodríguez-Díaz
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

6.  Multiple-dose therapy with bovine colostrum confers significant protection against diarrhea in a mouse model of human rotavirus-induced gastrointestinal disease.

Authors:  M Inagaki; M Yamamoto; T Yabe; K Uchida; M Kawasaki; T Nakagomi; O Nakagomi; N Minamoto; Y Kanamaru
Journal:  J Dairy Sci       Date:  2012-11-29       Impact factor: 4.034

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.